Trazium

Trazium
Systematic (IUPAC) name
	1-(4-chlorophenyl)-1-hydroxy-1,4-dihydro[1,2,4]triazino[6,1-a]isoquinolin-5-ium
Clinical data
Routes of; administration	Oral
Legal status
Legal status	Uncontrolled;
Identifiers
CAS Number	97110-59-3
ATC code	none
PubChem	CID 72166
ChemSpider	65139
Chemical data
Formula	C17H13ClN3O
Molar mass	310.76 g/mol

Trazium (EGYT-3,615) is an antidepressant drug which was never marketed.^[1] It has psychostimulant-like effects and its actions appear to be mediated by the dopaminergic and adrenergic systems.^[2]

References[edit]

^ David J. Triggle (1996). Dictionary of Pharmacological Agents. Boca Raton: Chapman & Hall/CRC. ISBN 0-412-46630-9.
^ Gyertyán I, Petöcz L, Bajnógel J, et al. (July 1989). "Possible involvement of the dopaminergic system in the mode of action of the potential antidepressant trazium esilate". Arzneimittel-Forschung 39 (7): 775–81. PMID 2551306.

Systematic (IUPAC) name

1-(4-chlorophenyl)-1-hydroxy-1,4-dihydro[1,2,4]triazino[6,1-a]isoquinolin-5-ium
Clinical data
Routes of administration	Oral
Legal status
Legal status	Uncontrolled
Identifiers
CAS Number	97110-59-3
ATC code	none
PubChem	CID 72166
ChemSpider	65139
Chemical data
Formula	C₁₇H₁₃ClN₃O
Molar mass	310.76 g/mol